WO2000053086A9 - Method for determining analyte concentration using periodic temperature modulation and phase detection - Google Patents
Method for determining analyte concentration using periodic temperature modulation and phase detectionInfo
- Publication number
- WO2000053086A9 WO2000053086A9 PCT/US2000/006348 US0006348W WO0053086A9 WO 2000053086 A9 WO2000053086 A9 WO 2000053086A9 US 0006348 W US0006348 W US 0006348W WO 0053086 A9 WO0053086 A9 WO 0053086A9
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- signal
- gradient
- analytical
- inducing
- sample
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 127
- 239000012491 analyte Substances 0.000 title claims abstract description 119
- 230000000737 periodic effect Effects 0.000 title claims description 17
- 238000001514 detection method Methods 0.000 title description 6
- 238000012360 testing method Methods 0.000 claims abstract description 88
- 230000005855 radiation Effects 0.000 claims abstract description 74
- 230000001939 inductive effect Effects 0.000 claims abstract description 42
- 238000005259 measurement Methods 0.000 claims abstract description 36
- 238000002835 absorbance Methods 0.000 claims description 55
- 210000004369 blood Anatomy 0.000 claims description 52
- 239000008280 blood Substances 0.000 claims description 52
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 47
- 239000008103 glucose Substances 0.000 claims description 47
- 241000282414 Homo sapiens Species 0.000 claims description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 27
- 239000000126 substance Substances 0.000 claims description 24
- 238000012545 processing Methods 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 239000000463 material Substances 0.000 claims description 17
- 230000005540 biological transmission Effects 0.000 claims description 14
- 241001465754 Metazoa Species 0.000 claims description 9
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 8
- 108010054147 Hemoglobins Proteins 0.000 claims description 7
- 102000001554 Hemoglobins Human genes 0.000 claims description 7
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 claims description 6
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 6
- 239000012620 biological material Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 4
- 239000001569 carbon dioxide Substances 0.000 claims description 4
- 235000012000 cholesterol Nutrition 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 102000009027 Albumins Human genes 0.000 claims description 3
- 108010088751 Albumins Proteins 0.000 claims description 3
- 102000004877 Insulin Human genes 0.000 claims description 3
- 108090001061 Insulin Proteins 0.000 claims description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 239000004202 carbamide Substances 0.000 claims description 3
- 229940109239 creatinine Drugs 0.000 claims description 3
- 210000003743 erythrocyte Anatomy 0.000 claims description 3
- 150000004665 fatty acids Chemical class 0.000 claims description 3
- 239000007789 gas Substances 0.000 claims description 3
- 229940088597 hormone Drugs 0.000 claims description 3
- 239000005556 hormone Substances 0.000 claims description 3
- 229940125396 insulin Drugs 0.000 claims description 3
- 150000002576 ketones Chemical class 0.000 claims description 3
- 210000000265 leukocyte Anatomy 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 230000002596 correlated effect Effects 0.000 abstract description 8
- 238000010521 absorption reaction Methods 0.000 abstract description 5
- 239000000523 sample Substances 0.000 description 147
- 238000001816 cooling Methods 0.000 description 35
- 210000003491 skin Anatomy 0.000 description 23
- 210000001519 tissue Anatomy 0.000 description 23
- 230000000694 effects Effects 0.000 description 20
- 238000004458 analytical method Methods 0.000 description 18
- 238000010438 heat treatment Methods 0.000 description 17
- 239000000470 constituent Substances 0.000 description 12
- 230000007423 decrease Effects 0.000 description 10
- 239000012530 fluid Substances 0.000 description 10
- 238000001727 in vivo Methods 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 238000000295 emission spectrum Methods 0.000 description 7
- 238000000338 in vitro Methods 0.000 description 7
- 231100000430 skin reaction Toxicity 0.000 description 7
- 238000004611 spectroscopical analysis Methods 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 5
- 238000000862 absorption spectrum Methods 0.000 description 5
- 239000013626 chemical specie Substances 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- 230000009102 absorption Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 210000003296 saliva Anatomy 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 239000013060 biological fluid Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000009103 reabsorption Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 230000036962 time dependent Effects 0.000 description 3
- 238000002235 transmission spectroscopy Methods 0.000 description 3
- 208000004434 Calcinosis Diseases 0.000 description 2
- 108010003320 Carboxyhemoglobin Proteins 0.000 description 2
- 102000018832 Cytochromes Human genes 0.000 description 2
- 108010052832 Cytochromes Proteins 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- 239000000538 analytical sample Substances 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 230000037323 metabolic rate Effects 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 238000013186 photoplethysmography Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000002834 transmittance Methods 0.000 description 2
- -1 urine Substances 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 1
- 230000005457 Black-body radiation Effects 0.000 description 1
- 206010048962 Brain oedema Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 230000008081 blood perfusion Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 208000006752 brain edema Diseases 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000007705 chemical test Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000027734 detection of oxygen Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000002977 intracellular fluid Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- 230000004783 oxidative metabolism Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000541 pulsatile effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002277 temperature effect Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000000287 tissue oxygenation Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000005353 urine analysis Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00913890A EP1158894A1 (en) | 1999-03-10 | 2000-03-10 | Method for determining analyte concentration using periodic temperature modulation and phase detection |
CA000000006A CA2362780A1 (en) | 1999-03-10 | 2000-03-10 | Method for determining analyte concentration using periodic temperature modulation and phase detection |
JP2000603579A JP2002537931A (en) | 1999-03-10 | 2000-03-10 | Method for measuring analyte concentration using periodic temperature control and phase detection |
AU35250/00A AU3525000A (en) | 1999-03-10 | 2000-03-10 | Method for determining analyte concentration using periodic temperature modulation and phase detection |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/267,121 US6161028A (en) | 1999-03-10 | 1999-03-10 | Method for determining analyte concentration using periodic temperature modulation and phase detection |
US09/267,121 | 1999-03-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000053086A1 WO2000053086A1 (en) | 2000-09-14 |
WO2000053086A9 true WO2000053086A9 (en) | 2001-10-25 |
Family
ID=23017403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/006348 WO2000053086A1 (en) | 1999-03-10 | 2000-03-10 | Method for determining analyte concentration using periodic temperature modulation and phase detection |
Country Status (6)
Country | Link |
---|---|
US (7) | US6161028A (en) |
EP (1) | EP1158894A1 (en) |
JP (1) | JP2002537931A (en) |
AU (1) | AU3525000A (en) |
CA (1) | CA2362780A1 (en) |
WO (1) | WO2000053086A1 (en) |
Families Citing this family (150)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6161028A (en) * | 1999-03-10 | 2000-12-12 | Optiscan Biomedical Corporation | Method for determining analyte concentration using periodic temperature modulation and phase detection |
US6036924A (en) | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US7043287B1 (en) * | 1998-05-18 | 2006-05-09 | Abbott Laboratories | Method for modulating light penetration depth in tissue and diagnostic applications using same |
US6393310B1 (en) * | 1998-09-09 | 2002-05-21 | J. Todd Kuenstner | Methods and systems for clinical analyte determination by visible and infrared spectroscopy |
US6959211B2 (en) | 1999-03-10 | 2005-10-25 | Optiscan Biomedical Corp. | Device for capturing thermal spectra from tissue |
US6633771B1 (en) * | 1999-03-10 | 2003-10-14 | Optiscan Biomedical Corporation | Solid-state non-invasive thermal cycling spectrometer |
AT408376B (en) * | 1999-04-07 | 2001-11-26 | Lendl Bernhard Dr | METHOD FOR INFRARED-OPTICALLY DETERMINING THE CONCENTRATION OF AT LEAST ONE ANALYTIC IN A LIQUID SAMPLE |
US6196046B1 (en) | 1999-08-25 | 2001-03-06 | Optiscan Biomedical Corporation | Devices and methods for calibration of a thermal gradient spectrometer |
US7509153B2 (en) * | 2000-09-26 | 2009-03-24 | Sensys Medical, Inc. | Method and apparatus for control of skin perfusion for indirect glucose measurement |
US6549861B1 (en) | 2000-08-10 | 2003-04-15 | Euro-Celtique, S.A. | Automated system and method for spectroscopic analysis |
WO2002016905A2 (en) | 2000-08-21 | 2002-02-28 | Euro-Celtique, S.A. | Near infrared blood glucose monitoring system |
US6640117B2 (en) | 2000-09-26 | 2003-10-28 | Sensys Medical, Inc. | Method and apparatus for minimizing spectral effects attributable to tissue state variations during NIR-based non-invasive blood analyte determination |
US20020107640A1 (en) * | 2000-11-14 | 2002-08-08 | Ideker Trey E. | Methods for determining the true signal of an analyte |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
DE60121731T2 (en) * | 2001-05-08 | 2007-08-02 | Agere Systems Guardian Corp., Miami Lakes | Cordless network system which includes access points |
DE60238119D1 (en) | 2001-06-12 | 2010-12-09 | Pelikan Technologies Inc | ELECTRIC ACTUATOR ELEMENT FOR A LANZETTE |
WO2002100254A2 (en) | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
ES2336081T3 (en) | 2001-06-12 | 2010-04-08 | Pelikan Technologies Inc. | SELF-OPTIMIZATION PUNCTURE DEVICE WITH MEANS OF ADAPTATION TO TEMPORARY VARIATIONS IN CUTANEOUS PROPERTIES. |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
EP1404234B1 (en) | 2001-06-12 | 2011-02-09 | Pelikan Technologies Inc. | Apparatus for improving success rate of blood yield from a fingerstick |
JP4272051B2 (en) | 2001-06-12 | 2009-06-03 | ペリカン テクノロジーズ インコーポレイテッド | Blood sampling apparatus and method |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US6802812B1 (en) * | 2001-07-27 | 2004-10-12 | Nostix Llc | Noninvasive optical sensor for measuring near infrared light absorbing analytes |
US6631282B2 (en) | 2001-08-09 | 2003-10-07 | Optiscan Biomedical Corporation | Device for isolating regions of living tissue |
US6678542B2 (en) * | 2001-08-16 | 2004-01-13 | Optiscan Biomedical Corp. | Calibrator configured for use with noninvasive analyte-concentration monitor and employing traditional measurements |
US20030108976A1 (en) | 2001-10-09 | 2003-06-12 | Braig James R. | Method and apparatus for improving clinical accuracy of analyte measurements |
US6989891B2 (en) | 2001-11-08 | 2006-01-24 | Optiscan Biomedical Corporation | Device and method for in vitro determination of analyte concentrations within body fluids |
US6731961B2 (en) * | 2001-11-09 | 2004-05-04 | Optiscan Biomedical Corp. | Method for transforming phase spectra to absorption spectra |
US6917038B2 (en) * | 2001-11-21 | 2005-07-12 | Optiscan Biomedical Corporation | Method and apparatus for adjusting signal variation of an electronically controlled infrared transmissive window |
AU2002346486A1 (en) | 2001-11-21 | 2003-06-10 | James R. Braig | Method for adjusting a blood analyte measurement |
US6862534B2 (en) * | 2001-12-14 | 2005-03-01 | Optiscan Biomedical Corporation | Method of determining an analyte concentration in a sample from an absorption spectrum |
US7009180B2 (en) * | 2001-12-14 | 2006-03-07 | Optiscan Biomedical Corp. | Pathlength-independent methods for optically determining material composition |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7291117B2 (en) | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7371247B2 (en) | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7708701B2 (en) | 2002-04-19 | 2010-05-04 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device |
US7175642B2 (en) | 2002-04-19 | 2007-02-13 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
EP1528890A1 (en) | 2002-08-14 | 2005-05-11 | Optiscan Biomedical Corporation | Device and method for in vitro determination of analyte concentrations within body fluids |
US7908324B2 (en) * | 2002-10-02 | 2011-03-15 | Disney Enterprises, Inc. | Multi-user interactive communication network environment |
US7233817B2 (en) * | 2002-11-01 | 2007-06-19 | Brian Yen | Apparatus and method for pattern delivery of radiation and biological characteristic analysis |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US6983177B2 (en) * | 2003-01-06 | 2006-01-03 | Optiscan Biomedical Corporation | Layered spectroscopic sample element with microporous membrane |
US20040132167A1 (en) * | 2003-01-06 | 2004-07-08 | Peter Rule | Cartridge lance |
US20040132168A1 (en) | 2003-01-06 | 2004-07-08 | Peter Rule | Sample element for reagentless whole blood glucose meter |
US7271912B2 (en) * | 2003-04-15 | 2007-09-18 | Optiscan Biomedical Corporation | Method of determining analyte concentration in a sample using infrared transmission data |
DK1633235T3 (en) | 2003-06-06 | 2014-08-18 | Sanofi Aventis Deutschland | Apparatus for sampling body fluid and detecting analyte |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
US20050043630A1 (en) * | 2003-08-21 | 2005-02-24 | Buchert Janusz Michal | Thermal Emission Non-Invasive Analyte Monitor |
EP1671096A4 (en) | 2003-09-29 | 2009-09-16 | Pelikan Technologies Inc | Method and apparatus for an improved sample capture device |
EP1680014A4 (en) | 2003-10-14 | 2009-01-21 | Pelikan Technologies Inc | Method and apparatus for a variable user interface |
EP1706026B1 (en) | 2003-12-31 | 2017-03-01 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for improving fluidic flow and sample capture |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
US7132657B2 (en) * | 2004-02-09 | 2006-11-07 | Sensor Electronics Corporation | Infrared gas detector |
US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
WO2005120365A1 (en) | 2004-06-03 | 2005-12-22 | Pelikan Technologies, Inc. | Method and apparatus for a fluid sampling device |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US7722537B2 (en) * | 2005-02-14 | 2010-05-25 | Optiscan Biomedical Corp. | Method and apparatus for detection of multiple analytes |
US8251907B2 (en) | 2005-02-14 | 2012-08-28 | Optiscan Biomedical Corporation | System and method for determining a treatment dose for a patient |
US20060189925A1 (en) * | 2005-02-14 | 2006-08-24 | Gable Jennifer H | Methods and apparatus for extracting and analyzing a component of a bodily fluid |
US7630848B2 (en) * | 2005-05-25 | 2009-12-08 | Foss Analytical A/B | Analysis system and method implementing distributed processing |
AU2006345002B2 (en) * | 2005-07-27 | 2012-02-02 | L-3 Communications Cyterra Corporation | Energetic material detector |
US8292496B1 (en) | 2005-07-27 | 2012-10-23 | L-3 Communications Cyterra Corporation | Energetic material detector |
EP1955653B1 (en) | 2005-11-30 | 2010-12-22 | Toshiba Medical Systems Corporation | Method of noninvasively measuring glucose |
US7729734B2 (en) * | 2006-03-07 | 2010-06-01 | Andreas Mandelis | Non-invasive biothermophotonic sensor for blood glucose monitoring |
US7473898B2 (en) * | 2006-05-17 | 2009-01-06 | The Boeing Company | Cryogenic terahertz spectroscopy |
CA2673059A1 (en) * | 2006-12-22 | 2008-07-03 | L-3 Communications Cyterra Corporation | Energetic material detector |
AT504436B8 (en) * | 2007-03-01 | 2008-09-15 | Anton Paar Gmbh | METHOD AND DEVICE FOR DETERMINING THE ALCOHOLIC STRENGTH OF LIQUIDS |
US20090018414A1 (en) * | 2007-03-23 | 2009-01-15 | Mehrdad Toofan | Subcutanous Blood Vessels Imaging System |
JP5303851B2 (en) * | 2007-04-03 | 2013-10-02 | 株式会社島津製作所 | Alcohol detection device |
US8597190B2 (en) | 2007-05-18 | 2013-12-03 | Optiscan Biomedical Corporation | Monitoring systems and methods with fast initialization |
US8417311B2 (en) | 2008-09-12 | 2013-04-09 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
EP2205147A1 (en) | 2007-10-10 | 2010-07-14 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
WO2009049245A1 (en) * | 2007-10-11 | 2009-04-16 | Optiscan Biomedical Corporation | Synchronization and configuration of patient monitoring devices |
US20090247853A1 (en) * | 2008-03-31 | 2009-10-01 | Nellcor Puritan Bennett Llc | Non-Invasive Total Hemoglobin Measurement by Spectral Optical Coherence Tomography |
US20110004080A1 (en) | 2008-04-11 | 2011-01-06 | Glucovista, Llc | Method for non-invasive analysis of a substance concentration within a body |
US9681832B2 (en) * | 2008-04-11 | 2017-06-20 | Glucovista Inc. | Measurement apparatuses and methods using a combined substance cooling device |
WO2009126900A1 (en) | 2008-04-11 | 2009-10-15 | Pelikan Technologies, Inc. | Method and apparatus for analyte detecting device |
US8193504B2 (en) * | 2008-05-03 | 2012-06-05 | Luca Joseph Gratton | Method and apparatus for the identification of lithospheric or shielded material deposits by doppler-shifted response photon spectra from interrogation by ionizing radiation |
US8035550B2 (en) * | 2008-07-03 | 2011-10-11 | The Boeing Company | Unbalanced non-linear radar |
US8106810B2 (en) | 2008-07-03 | 2012-01-31 | The Boeing Company | Millimeter wave filters |
US8130160B2 (en) * | 2008-07-03 | 2012-03-06 | The Boeing Company | Composite dipole array assembly |
US7959598B2 (en) | 2008-08-20 | 2011-06-14 | Asante Solutions, Inc. | Infusion pump systems and methods |
US20100112614A1 (en) * | 2008-11-06 | 2010-05-06 | Physical Logic Ag | Coupled Antenna Impedance Spectroscopy |
JP2012510843A (en) * | 2008-12-05 | 2012-05-17 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Joint state combined optical and thermographic detection apparatus, system and method |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US10475529B2 (en) | 2011-07-19 | 2019-11-12 | Optiscan Biomedical Corporation | Method and apparatus for analyte measurements using calibration sets |
US8649835B2 (en) * | 2009-11-17 | 2014-02-11 | Andreas Mandelis | Method of performing wavelength modulated differential laser photothermal radiometry with high sensitivity |
DE102010000701A1 (en) * | 2010-01-06 | 2011-07-07 | Ford Global Technologies, LLC, Mich. | Method and device for estimating the temperature felt when touching a surface |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8235897B2 (en) | 2010-04-27 | 2012-08-07 | A.D. Integrity Applications Ltd. | Device for non-invasively measuring glucose |
US20130226603A1 (en) * | 2010-12-31 | 2013-08-29 | Stephen Suffin | Delivery of Medical Services Based on Observed Parametric Variation in Analyte Values |
US8945936B2 (en) | 2011-04-06 | 2015-02-03 | Fresenius Medical Care Holdings, Inc. | Measuring chemical properties of a sample fluid in dialysis systems |
GB2523989B (en) | 2014-01-30 | 2020-07-29 | Insulet Netherlands B V | Therapeutic product delivery system and method of pairing |
US10588552B2 (en) | 2014-06-19 | 2020-03-17 | Glucovista Inc. | Substance concentration analysis methods and apparatuses |
JP6966200B2 (en) * | 2014-06-19 | 2021-11-10 | グルコビスタ・インコーポレイテッド | Substance concentration monitoring device and method |
US9459201B2 (en) | 2014-09-29 | 2016-10-04 | Zyomed Corp. | Systems and methods for noninvasive blood glucose and other analyte detection and measurement using collision computing |
CN111905188B (en) | 2015-02-18 | 2022-07-22 | 英赛罗公司 | Fluid delivery and infusion device and method of use |
US10139407B2 (en) | 2016-04-11 | 2018-11-27 | Universiteit Maastricht | Methods for detecting bacteria using polymer materials |
CN108369197B (en) * | 2015-11-16 | 2020-09-15 | 马斯特里赫特大学 | Apparatus and method for detecting analytes using thermal waves |
EP3374905A1 (en) | 2016-01-13 | 2018-09-19 | Bigfoot Biomedical, Inc. | User interface for diabetes management system |
CN112933333B (en) | 2016-01-14 | 2023-03-28 | 比格福特生物医药公司 | Adjusting insulin delivery rate |
US9554738B1 (en) | 2016-03-30 | 2017-01-31 | Zyomed Corp. | Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing |
US10324087B2 (en) | 2016-04-11 | 2019-06-18 | Universiteit Maastricht | Thermocouples comprising a polymer for detecting analytes and related methods |
US10765807B2 (en) | 2016-09-23 | 2020-09-08 | Insulet Corporation | Fluid delivery device with sensor |
US20180271417A1 (en) * | 2017-03-21 | 2018-09-27 | Wipro Limited | Method and a device for non-invasive monitoring of a blood glucose level of a user |
KR102491750B1 (en) | 2017-08-21 | 2023-01-26 | 도쿄엘렉트론가부시키가이샤 | Optical sensor for phase determination |
USD928199S1 (en) | 2018-04-02 | 2021-08-17 | Bigfoot Biomedical, Inc. | Medication delivery device with icons |
AU2019263490A1 (en) | 2018-05-04 | 2020-11-26 | Insulet Corporation | Safety constraints for a control algorithm-based drug delivery system |
CN112789070A (en) | 2018-09-28 | 2021-05-11 | 英赛罗公司 | Mode of activity of the artificial pancreas System |
WO2020077223A1 (en) | 2018-10-11 | 2020-04-16 | Insulet Corporation | Event detection for drug delivery system |
KR20200043184A (en) * | 2018-10-17 | 2020-04-27 | 삼성전자주식회사 | Apparatus and method for processing spectrum according to change of object temperature |
USD920343S1 (en) | 2019-01-09 | 2021-05-25 | Bigfoot Biomedical, Inc. | Display screen or portion thereof with graphical user interface associated with insulin delivery |
US11801344B2 (en) | 2019-09-13 | 2023-10-31 | Insulet Corporation | Blood glucose rate of change modulation of meal and correction insulin bolus quantity |
US11935637B2 (en) | 2019-09-27 | 2024-03-19 | Insulet Corporation | Onboarding and total daily insulin adaptivity |
US11957875B2 (en) | 2019-12-06 | 2024-04-16 | Insulet Corporation | Techniques and devices providing adaptivity and personalization in diabetes treatment |
US11833329B2 (en) | 2019-12-20 | 2023-12-05 | Insulet Corporation | Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns |
US11551802B2 (en) | 2020-02-11 | 2023-01-10 | Insulet Corporation | Early meal detection and calorie intake detection |
US11547800B2 (en) | 2020-02-12 | 2023-01-10 | Insulet Corporation | User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system |
US11324889B2 (en) | 2020-02-14 | 2022-05-10 | Insulet Corporation | Compensation for missing readings from a glucose monitor in an automated insulin delivery system |
US11607493B2 (en) | 2020-04-06 | 2023-03-21 | Insulet Corporation | Initial total daily insulin setting for user onboarding |
US11684716B2 (en) | 2020-07-31 | 2023-06-27 | Insulet Corporation | Techniques to reduce risk of occlusions in drug delivery systems |
US10952655B1 (en) * | 2020-09-21 | 2021-03-23 | The Florida International University Board Of Trustees | Retinal blood vessel oximetry using retinal auofluorescence |
US11904140B2 (en) | 2021-03-10 | 2024-02-20 | Insulet Corporation | Adaptable asymmetric medicament cost component in a control system for medicament delivery |
US11738144B2 (en) | 2021-09-27 | 2023-08-29 | Insulet Corporation | Techniques enabling adaptation of parameters in aid systems by user input |
US11439754B1 (en) | 2021-12-01 | 2022-09-13 | Insulet Corporation | Optimizing embedded formulations for drug delivery |
Family Cites Families (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3958560A (en) * | 1974-11-25 | 1976-05-25 | Wayne Front March | Non-invasive automatic glucose sensor system |
DE2606991A1 (en) * | 1976-02-20 | 1977-08-25 | Nils Dr Med Kaiser | DEVICE FOR DETERMINING THE CONTENT OF METABOLIC PRODUCTS IN THE BLOOD |
US4429999A (en) | 1981-06-22 | 1984-02-07 | Bimberg Dieter H | Method for calorimetric absorption spectroscopy and device for working the method |
US4655225A (en) * | 1985-04-18 | 1987-04-07 | Kurabo Industries Ltd. | Spectrophotometric method and apparatus for the non-invasive |
JPS6323645A (en) | 1986-05-27 | 1988-01-30 | 住友電気工業株式会社 | Reflection heating type oxymeter |
US5473162A (en) | 1987-10-26 | 1995-12-05 | Baylor University | Infrared emission detection of a gas |
US5009230A (en) * | 1988-05-31 | 1991-04-23 | Eol, Inc. | Personal glucose monitor |
US5361758A (en) | 1988-06-09 | 1994-11-08 | Cme Telemetrix Inc. | Method and device for measuring concentration levels of blood constituents non-invasively |
US5122974A (en) | 1989-02-06 | 1992-06-16 | Nim, Inc. | Phase modulated spectrophotometry |
US5187672A (en) | 1989-02-06 | 1993-02-16 | Nim Incorporated | Phase modulation spectroscopic system |
US5075552A (en) * | 1989-01-13 | 1991-12-24 | Iowa State University Research Foundation Inc. | Apparatus and method for transient thermal infrared emission spectrometry |
US5191215A (en) * | 1989-01-13 | 1993-03-02 | Iowa State University Research Foundation, Inc. | Apparatus and method for transient thermal infrared spectrometry of flowable enclosed materials |
US5040539A (en) | 1989-05-12 | 1991-08-20 | The United States Of America | Pulse oximeter for diagnosis of dental pulp pathology |
US5137023A (en) * | 1990-04-19 | 1992-08-11 | Worcester Polytechnic Institute | Method and apparatus for monitoring blood analytes noninvasively by pulsatile photoplethysmography |
US5112124A (en) | 1990-04-19 | 1992-05-12 | Worcester Polytechnic Institute | Method and apparatus for measuring the concentration of absorbing substances |
US5372136A (en) | 1990-10-06 | 1994-12-13 | Noninvasive Medical Technology Corporation | System and method for noninvasive hematocrit monitoring |
US5209231A (en) | 1990-11-02 | 1993-05-11 | University Of Connecticut | Optical glucose sensor apparatus and method |
US5243983A (en) | 1990-12-14 | 1993-09-14 | Georgia Tech Research Corporation | Non-invasive blood glucose measurement system and method using stimulated raman spectroscopy |
JP3224540B2 (en) | 1991-07-03 | 2001-10-29 | ビバスキヤン・コーポレーシヨン | Apparatus for measuring components of human or animal tissues |
AU2245092A (en) | 1991-12-31 | 1993-07-28 | Vivascan Corporation | Blood constituent determination based on differential spectral analysis |
AU3583293A (en) | 1992-01-17 | 1993-08-03 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Optical method for monitoring arterial blood hematocrit |
US5370114A (en) | 1992-03-12 | 1994-12-06 | Wong; Jacob Y. | Non-invasive blood chemistry measurement by stimulated infrared relaxation emission |
US5672875A (en) * | 1992-07-15 | 1997-09-30 | Optix Lp | Methods of minimizing scattering and improving tissue sampling in non-invasive testing and imaging |
US5348003A (en) | 1992-09-03 | 1994-09-20 | Sirraya, Inc. | Method and apparatus for chemical analysis |
DE69319050T2 (en) | 1992-09-25 | 1998-10-08 | Texaco Development Corp | Aircraft measurement method and device |
IL107396A (en) | 1992-11-09 | 1997-02-18 | Boehringer Mannheim Gmbh | Method and apparatus for analytical determination of glucose in a biological matrix |
US5360004A (en) | 1992-12-09 | 1994-11-01 | Diasense, Inc. | Non-invasive determination of analyte concentration using non-continuous radiation |
JPH07506039A (en) | 1992-12-10 | 1995-07-06 | サンシャイン メディカル インスツルメンツ インコーポレイテッド | Non-invasive blood glucose measurement |
US5615672A (en) * | 1993-01-28 | 1997-04-01 | Optiscan, Inc. | Self-emission noninvasive infrared spectrophotometer with body temperature compensation |
US5515847A (en) | 1993-01-28 | 1996-05-14 | Optiscan, Inc. | Self-emission noninvasive infrared spectrophotometer |
US5313941A (en) * | 1993-01-28 | 1994-05-24 | Braig James R | Noninvasive pulsed infrared spectrophotometer |
US5451787A (en) | 1993-05-04 | 1995-09-19 | Westinghouse Electric Corporation | Hazardous air pollutants monitor |
US5383452A (en) | 1993-07-01 | 1995-01-24 | Buchert; Janusz | Method, apparatus and procedure for non-invasive monitoring blood glucose by measuring the polarization ratio of blood luminescence |
US5492118A (en) | 1993-12-16 | 1996-02-20 | Board Of Trustees Of The University Of Illinois | Determining material concentrations in tissues |
US5553615A (en) | 1994-01-31 | 1996-09-10 | Minnesota Mining And Manufacturing Company | Method and apparatus for noninvasive prediction of hematocrit |
US5580177A (en) * | 1994-03-29 | 1996-12-03 | Hewlett-Packard Company | Printer/client network with centrally updated printer drivers and printer status monitoring |
DE4417639A1 (en) | 1994-05-19 | 1995-11-23 | Boehringer Mannheim Gmbh | Analysis of concns. of substances in a biological sample |
US5461229A (en) | 1994-06-06 | 1995-10-24 | Unisys Corporation | On-the-go optical spectroscopy soil analyzer |
DE4423663A1 (en) * | 1994-07-06 | 1996-01-11 | Med Science Gmbh | Method and device for detecting thermal interactions between the human body and the device according to the invention and their correlation with the glucose concentration in human blood |
US5692503A (en) | 1995-03-10 | 1997-12-02 | Kuenstner; J. Todd | Method for noninvasive (in-vivo) total hemoglobin, oxyhemogolobin, deoxyhemoglobin, carboxyhemoglobin and methemoglobin concentration determination |
US5823677A (en) * | 1996-03-18 | 1998-10-20 | The Board Of Trustees Of Western Michigan | Method of identifying a substance by infrared imaging |
US5666956A (en) | 1996-05-20 | 1997-09-16 | Buchert; Janusz Michal | Instrument and method for non-invasive monitoring of human tissue analyte by measuring the body's infrared radiation |
AU3721997A (en) * | 1996-07-19 | 1998-02-10 | Alexander K. Mills | Device for noninvasive determination of blood parameters |
JPH1051065A (en) * | 1996-08-02 | 1998-02-20 | Matsushita Electron Corp | Semiconductor laser device |
JP4212007B2 (en) | 1996-11-26 | 2009-01-21 | パナソニック電工株式会社 | Blood component concentration analyzer |
US5900632A (en) * | 1997-03-12 | 1999-05-04 | Optiscan Biomedical Corporation | Subsurface thermal gradient spectrometry |
US6161028A (en) * | 1999-03-10 | 2000-12-12 | Optiscan Biomedical Corporation | Method for determining analyte concentration using periodic temperature modulation and phase detection |
JP3226854B2 (en) * | 1997-10-24 | 2001-11-05 | 日本電気株式会社 | Semiconductor laser module |
EP1073366B1 (en) | 1998-04-24 | 2004-06-23 | Lightouch Medical, Inc. | Apparatus and method for thermal tissue modulation |
US6002953A (en) * | 1998-05-06 | 1999-12-14 | Optix Lp | Non-invasive IR transmission measurement of analyte in the tympanic membrane |
US6662030B2 (en) * | 1998-05-18 | 2003-12-09 | Abbott Laboratories | Non-invasive sensor having controllable temperature feature |
US6606162B1 (en) * | 1999-07-21 | 2003-08-12 | Hewlett-Packard Development Company, L.P. | Network printer groups |
US6915337B1 (en) * | 2000-03-07 | 2005-07-05 | Ricoh Co. Ltd. | Method and system for updating the device driver of a business office appliance |
US6886111B1 (en) * | 2000-03-08 | 2005-04-26 | International Business Machines Corporation | Method and data processing system for software testing of a device driver |
US20020067504A1 (en) * | 2000-12-06 | 2002-06-06 | Xerox Corporation | Method and apparatus for automatic upgrade of a product's printer driver |
US20030110412A1 (en) * | 2001-06-19 | 2003-06-12 | Xerox Corporation | System and method for automated printer diagnostics |
JP2003308215A (en) * | 2002-02-14 | 2003-10-31 | Canon Inc | Information processor, control method, and control program |
ITMN20020012A1 (en) * | 2002-04-04 | 2003-10-06 | Amfag Spa | TAP WITH REMOVABLE DISPENSER |
US20040227973A1 (en) * | 2002-04-04 | 2004-11-18 | Taylor Jarrett D. | System and method for distributing printer properties on a computer network |
US7146542B2 (en) * | 2002-12-20 | 2006-12-05 | Hewlett-Packard Development Company, L.P. | Method and apparatus for diagnosis and repair of computer devices and device drivers |
US7457831B2 (en) * | 2003-03-31 | 2008-11-25 | Microsoft Corporation | Peripheral device driver maintenance scheme for networked peripheral device clients |
-
1999
- 1999-03-10 US US09/267,121 patent/US6161028A/en not_active Expired - Fee Related
-
2000
- 2000-03-10 CA CA000000006A patent/CA2362780A1/en not_active Abandoned
- 2000-03-10 WO PCT/US2000/006348 patent/WO2000053086A1/en not_active Application Discontinuation
- 2000-03-10 AU AU35250/00A patent/AU3525000A/en not_active Abandoned
- 2000-03-10 JP JP2000603579A patent/JP2002537931A/en active Pending
- 2000-03-10 EP EP00913890A patent/EP1158894A1/en not_active Withdrawn
- 2000-03-30 US US09/538,164 patent/US6580934B1/en not_active Expired - Fee Related
- 2000-09-15 US US09/663,071 patent/US6556850B1/en not_active Expired - Fee Related
- 2000-09-15 US US09/663,114 patent/US6577885B1/en not_active Expired - Fee Related
-
2003
- 2003-02-27 US US10/377,020 patent/US20040034291A1/en not_active Abandoned
- 2003-04-28 US US10/426,160 patent/US7006857B2/en not_active Expired - Fee Related
- 2003-06-06 US US10/456,109 patent/US6944486B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6556850B1 (en) | 2003-04-29 |
US20040087841A1 (en) | 2004-05-06 |
EP1158894A1 (en) | 2001-12-05 |
AU3525000A (en) | 2000-09-28 |
US20040034291A1 (en) | 2004-02-19 |
US6161028A (en) | 2000-12-12 |
US7006857B2 (en) | 2006-02-28 |
US6580934B1 (en) | 2003-06-17 |
US6577885B1 (en) | 2003-06-10 |
US20030199742A1 (en) | 2003-10-23 |
US6944486B2 (en) | 2005-09-13 |
CA2362780A1 (en) | 2000-09-14 |
JP2002537931A (en) | 2002-11-12 |
WO2000053086A1 (en) | 2000-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6161028A (en) | Method for determining analyte concentration using periodic temperature modulation and phase detection | |
US6025597A (en) | Non-invasive infrared absorption spectrometer for measuring glucose or other constituents in a human or other body | |
US5460177A (en) | Method for non-invasive measurement of concentration of analytes in blood using continuous spectrum radiation | |
US6289230B1 (en) | Tissue modulation process for quantitative noninvasive in vivo spectroscopic analysis of tissues | |
JP3590409B2 (en) | Self-luminous non-invasive infrared spectrophotometer with temperature compensation | |
US5515847A (en) | Self-emission noninvasive infrared spectrophotometer | |
US6615061B1 (en) | Optical sensor having a selectable sampling distance for determination of analytes | |
JP2001507457A (en) | Non-invasive infrared absorption spectrometer for temperature gradient spectra | |
US20030178569A1 (en) | Pathlength-independent methods for optically determining material composition | |
JP2003245266A (en) | Highly reliable noninvasive blood gas measuring method | |
EP1328191A1 (en) | Method for the non-invasive determination of an analyte in a selected volume of tissue | |
Heise | Medical applications of NIR spectroscopy | |
Pleitez et al. | Infrared reflectometry of skin: Analysis of backscattered light from different skin layers | |
Ogawa et al. | A New, Non-Invasive in vivo Optical Blood Glucose Measurement Technique Using Near-Infrared Radiation (“Pulse Glucometry”) and a Proposal for “Pulse Hemo-Photometry” Blood Constituent Measurements | |
Shih et al. | Introduction to spectroscopy for noninvasive glucose sensing | |
Saetchnikov et al. | Point of care fiber optical sensor for non-invasive multi parameter monitoring of blood and human tissue biochemistry | |
Khalil | Non-invasive monitoring of diabetes: Specificity, compartmentalization, and calibration issues | |
Khalil | Progress in noninvasive optical diagnostics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 35250/00 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2362780 Country of ref document: CA Ref country code: CA Ref document number: 2362780 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000913890 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 603579 Kind code of ref document: A Format of ref document f/p: F |
|
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: PAGE 34, CLAIMS, ADDED; PAGES 1/20-20/20, DRAWINGS, REPLACED BY NEW PAGES 1/20-20/20; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
WWP | Wipo information: published in national office |
Ref document number: 2000913890 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000913890 Country of ref document: EP |